Project #541

Project #541 - FORENAP - France

Date: 2008/10/23 Deadline: 2039/12/12

Contact

Organisation FORENAP Department  
Contact person GRAFF, Mrs Caroline
Email caroline.graff@forenap.com
Address 27, rue du 4ème RSM
B.P. 27
Postcode 68250 City ROUFFACH
Country France
Telephone 0033-389-78-73-82 Fax  
Website www.forenap.com
Familiar with the European Framework Programme? YES

PROJECT

Title: New translational strategies for cognitive dysfunction treatments of Schizophrenia Acronym: STIGMA

Project type Large-scale integrating collaborative project
Status Planned for submission
Call references FP7 Call 3

Priorities’ Main Research Areas Clinical trials in Psychiatry, animals models, knock-out, genetics, pharmacology, neuroimaging, pathophysiology
Workprogramme Topic (according to each priority workprogramme)
Project description
The multidisciplinary STIGMA consortium aims are focused on new tools development enabling the
Schizophrenia community to accelerate the research on mechanisms of action (MOA) and the drug
development for treatments targeting cognitive dysfunction.
Keywords Schizophrenia, cognition, treatment, clinical studies, genetics, animal models , prefrontal cortex
Partners already involved  
Project budget (for the running projects) nc Budget reserved for SMEs nc

Research topics

• HEALTH- 2009-2.2.1-3: Optimising current therapeutic approaches to schizophrenia. FP7-HEALTH-2009-single-stage.

Profile of SME sought

Role research, training, dissemination, other
Country /region All european countries except France
Start of partnership start-up phase
Expertise required Request for several partners:
* Expertise in all kind of disseminations (public, scientific, etc...) with various methods: organisation of workshop, meeting and writing project leaflets, posters, etc....
* Expertise in training: organising training seminaries for medical researchers and summer schools for students
* Expertise in health economic studies in schizophrenia.
* Expertise in psychiatry and clinical trials in patients.
* Expertise in transcranial magnetic stimulation in healthy subjects, induction of cognitive dysfunctions